Metraipolis › archive › dc_98f4eee52256
Camelid-Derived Nanobodies Targeting Human Epidermal Growth Factor Receptor: Screening, Expression, and Functional Validation — Europe PMC PMID:41874024
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41874024
- DOI
- 10.3390/antib15020019
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T08:21:52.052Z
- SHA-256 of the archived text
92d10368768dac4da4ab34c6f0d386dfda7b1bc51c6e88be5a99fdca10f65931- Stable URL of this page
https://metraipolis.com/documento/dc_98f4eee52256
How to cite
Camelid-Derived Nanobodies Targeting Human Epidermal Growth Factor Receptor: Screening, Expression, and Functional Validation — Europe PMC PMID:41874024 — Europe PMC (en), https://europepmc.org/article/MED/41874024 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_98f4eee52256 (Metraipolis archive dc_98f4eee52256, sha256 92d10368768dac4da4ab34c6f0d386dfda7b1bc51c6e88be5a99fdca10f65931)
BibTeX
@misc{dc98f4eee52256,
title = {Camelid-Derived Nanobodies Targeting Human Epidermal Growth Factor Receptor: Screening, Expression, and Functional Validation — Europe PMC PMID:41874024},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41874024},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_98f4eee52256; sha256 92d10368768dac4da4ab34c6f0d386dfda7b1bc51c6e88be5a99fdca10f65931},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41874024. Agents can read the archived copy with the MCP tool read_document.